Investors Research Corp raised its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2,555.6% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,195 shares of the healthcare conglomerate's stock after purchasing an additional 1,150 shares during the quarter. Investors Research Corp's holdings in UnitedHealth Group were worth $373,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Citizens National Bank Trust Department grew its holdings in shares of UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after purchasing an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH raised its stake in shares of UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after acquiring an additional 1,465 shares during the period. Caitlin John LLC boosted its position in UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after purchasing an additional 111 shares during the period. Sherbrooke Park Advisers LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at about $515,000. Finally, Silvercrest Asset Management Group LLC boosted its position in shares of UnitedHealth Group by 47.8% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock worth $19,625,000 after buying an additional 12,550 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.
Analyst Upgrades and Downgrades
UNH has been the subject of a number of analyst reports. Piper Sandler decreased their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. KeyCorp dropped their target price on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Finally, Wells Fargo & Company lowered their price objective on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average target price of $358.95.
View Our Latest Report on UNH
UnitedHealth Group Stock Performance
UNH stock opened at $352.61 on Friday. The firm has a market cap of $319.35 billion, a P/E ratio of 15.28, a P/E/G ratio of 2.31 and a beta of 0.45. The stock's 50 day simple moving average is $291.98 and its 200 day simple moving average is $369.01. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the company posted $6.80 earnings per share. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio is 38.30%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.